missing translation for 'onlineSavingsMsg'
Learn More
Learn More
anti-ICOS/CD278 APC, Clone: ISA-3, Invitrogen™
ICOS/CD278 Monoclonal antibody A14773 from Invitrogen specifically detects ICOS/CD278 in Human samples. It is validated for Flow Cytometry.
Brand: Invitrogen A14773
This item is not returnable.
View return policy
Description
ICOS/CD278 Monoclonal antibody A14773 from Invitrogen specifically detects ICOS/CD278 in Human samples. It is validated for Flow Cytometry.
CD278 belongs to the CD28 and CTLA-4 cell-surface receptor family and is highly expressed in activated T-cells. It is essential both for efficient interaction between T and B-cells and for normal antibody responses to T-cell dependent antigens. It enhances all basic T-cell responses to a foreign antigen, namely proliferation, secretion of lymphokines, up-regulation of molecules that mediate cell-cell interaction, and effective help for antibody secretion by B-cells.Host Species: Mouse
Cross Reactivity: Human
Isotype: IgG1
Clone: ISA-3
Immunogen: Human ICOS
Formulation: 25 Tests Purified Antibody in proprietary buffer, with 0.09% sodium azide
Synonyms: AILIM, CD278, CVID1, activation-inducible lymphocyte immunomediatory molecule, inducible T-cell costimulator, inducible costimulator
Uniprot Accession: Q9Y6W8
Entrez GeneID: 29851
Gene Symbol: ICOS
This product detects ICOS/CD278 in Human samples. This product has been successfully used in Flow Cytometry procedures. The immunogen is Human ICOS.
Specifications
| ICOS/CD278 | |
| Monoclonal | |
| APC | |
| Q9Y6W8 | |
| ICOS | |
| Human ICOS | |
| Primary | |
| Human | |
| Purified |
| Flow Cytometry | |
| ISA-3 | |
| 25 Tests Purified Antibody in proprietary buffer, with 0.09% sodium azide | |
| AILIM, CD278, CVID1, activation-inducible lymphocyte immunomediatory molecule, inducible T-cell costimulator, inducible costimulator | |
| Mouse | |
| 25 Tests | |
| 29851 | |
| Store at 4° C | |
| IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction